Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
CUSIP: 87650L103
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 42,450,857
- Total 13F shares
- 19,980,650
- Share change
- +6,771,529
- Total reported value
- $291,715,823
- Price per share
- $14.60
- Number of holders
- 70
- Value change
- +$98,791,820
- Number of buys
- 51
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 87650L103?
CUSIP 87650L103 identifies TARS - Tarsus Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87650L103:
Top shareholders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vivo Capital, LLC |
13F
|
Company |
7%
|
2,987,331
|
$50,247,000 | — | 31 Mar 2022 | |
| Vivo Capital IX, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,469,001
|
$49,380,020 | — | 05 May 2022 | |
| RTW INVESTMENTS, LP |
3/4/5
13F
|
10%+ Owner · Company |
4.7%
from 13F
|
2,013,601
|
$40,272,020 | — | 07 May 2021 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
3.3%
|
1,417,157
|
$23,837,000 | — | 31 Mar 2022 | |
| Cormorant Asset Management, LP |
13F
|
Company |
3.2%
|
1,375,982
|
$23,144,000 | — | 31 Mar 2022 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.1%
|
1,296,416
|
$21,805,000 | — | 31 Mar 2022 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
1.6%
|
659,600
|
$11,094,000 | — | 31 Mar 2022 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
1.3%
|
534,524
|
$8,991,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
458,816
|
$7,717,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1%
|
439,958
|
$7,400,000 | — | 31 Mar 2022 | |
| Jefferies Group LLC |
13F
|
Company |
0.95%
|
402,758
|
$6,774,390 | — | 31 Mar 2022 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.71%
|
300,000
|
$5,046,000 | — | 31 Mar 2022 | |
| Sands Capital Alternatives, LLC |
13F
|
Company |
0.61%
|
260,000
|
$4,373,000 | — | 31 Mar 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.57%
|
242,451
|
$4,079,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.31%
|
132,883
|
$2,235,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.31%
|
130,758
|
$2,199,000 | — | 31 Mar 2022 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.28%
|
120,000
|
$2,018,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
68,732
|
$1,156,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.11%
|
48,583
|
$818,000 | — | 31 Mar 2022 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.1%
|
42,439
|
$714,000 | — | 31 Mar 2022 | |
| DLD Asset Management, LP |
13F
|
Company |
0.08%
|
32,500
|
$547,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.07%
|
28,855
|
$485,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.07%
|
28,256
|
$475,000 | — | 31 Mar 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.07%
|
27,982
|
$471,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
25,111
|
$423,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
25,101
|
$422,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.05%
|
21,763
|
$381,000 | — | 31 Mar 2022 | |
| Michael Ackermann |
3/4/5
|
Director |
—
mixed-class rows
|
19,000
mixed-class rows
|
$272,650 | — | 16 Jun 2022 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.03%
|
12,760
|
$214,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
11,211
|
$188,000 | — | 31 Mar 2022 | |
| J. Goldman & Co LP |
13F
|
Company |
0.02%
|
10,544
|
$177,000 | — | 31 Mar 2022 | |
| Jason E. Tester |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
10,000
|
$109,900 | — | 15 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
6,499
|
$109,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
6,424
|
$108,000 | — | 31 Mar 2022 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
5,881
|
$99,000 | — | 31 Mar 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
4,726
|
$79,000 | — | 31 Mar 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
4,713
|
$79,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
4,226
|
$71,000 | — | 31 Mar 2022 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
4,186
|
$70,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
3,954
|
$67,000 | — | 31 Mar 2022 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
3,615
|
$61,000 | — | 31 Mar 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
2,593
|
$44,000 | — | 31 Mar 2022 | |
| STRS OHIO |
13F
|
Company |
0%
|
2,100
|
$35,000 | — | 31 Mar 2022 | |
| AMALGAMATED BANK |
13F
|
Company |
0%
|
1,306
|
$22,000 | — | 31 Mar 2022 | |
| Amalgamated Financial Corp. |
13F
|
Company |
0%
|
1,306
|
$22,000 | — | 31 Mar 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
868
|
$15,000 | — | 31 Mar 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
737
|
$13,000 | — | 31 Mar 2022 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
515
|
$9,000 | — | 31 Mar 2022 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
316
|
$5,000 | — | 31 Mar 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
200
|
$3,000 | — | 31 Mar 2022 |
Institutional Holders of Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) as of Q2 2022
As of 30 Jun 2022,
Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,980,650 shares.
The largest 10 holders included
Vivo Capital, LLC, TANG CAPITAL MANAGEMENT LLC, RTW INVESTMENTS, LP, Cormorant Asset Management, LP, Frazier Life Sciences Management, L.P., TimesSquare Capital Management, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), PERCEPTIVE ADVISORS LLC, BlackRock Inc., and VANGUARD GROUP INC.
This page lists
70
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
50
Q2 2022 holders
70
Holder diff
20
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.